88 results on '"Cote N"'
Search Results
2. PROGNOSTIC VALUE OF HUMAN EPIDIDYMIS PROTEIN 4 FOLLOWING TRANSCATHETER AORTIC VALVE IMPLANTATION
3. PROGNOSTIC VALUE OF CARDIAC DAMAGE STAGING CLASSIFICATION IN CHRONIC AORTIC REGURGITATION
4. MODULATION OF GENE EXPRESSION IN STENOTIC AORTIC VALVES OF WOMEN
5. INCREMENTAL VALUE OF BLOOD BIOMARKERS IN CARDIAC DAMAGE STAGING CLASSIFICATION AND THE EVOLUTION OF CARDIAC DAMAGE AFTER AORTIC VALVE REPLACEMENT IN ASYMPTOMATIC AORTIC VALVE STENOSIS
6. ASSOCIATION OF D-DIMERS WITH LEFT VENTRICULAR HYPERTROPHY AND CLINICAL OUTCOMES IN MILD TO MODERATE AORTIC STENOSIS: RESULTS FROM THE PROGRESSA STYDY
7. PROGNOSTIC VALUE OF PULMONARY HYPERTENSION IN PATIENTS WITH LOW-FLOW LOW-GRADIENT AORTIC STENOSIS
8. INFLUENCE OF AORTIC VALVE PHENOTYPE, MORPHOLOGY AND SEX ON ASCENDING AORTA DILATION
9. P246Insulin resistance predicts progression of left ventricular hypertrophy in patients with aortic stenosis: a substudy of the ASTRONOMER trial
10. Surgical repair of radial carpal bone fractures in two racehorses.
11. TIMING AND DETERMINANTS OF THE DETERIORATION OF FUNCTIONAL STATUS IN PATIENTS WITH AORTIC STENOSIS
12. SEX DIFFERENCES IN AORTIC STENOSIS PROGRESSION IN A MURINE MODEL
13. Comparison of the In Situ and In Vivo Intestinal Disappearance of Ruminally Protected Methionine
14. POS-758 IMPACT OF REDUCTION OF ARTERIAL STIFFNESS AFTER KIDNEY TRANSPLANT ON RADIAL ARTERY SYSTOLIC-DIASTOLIC PEAK-TO-PEAK TRANSIT TIME
15. POS-712 Reservoir-wave approach to arterial pressure wave after kidney transplantation
16. Reclassification of prosthesis-patient mismatch after transcatheter aortic valve replacement using predicted versus measured indexed effective orifice area
17. A012 – CURRENT UTILIZATION OF AEROBIC EXERCISE IN ADULT NEUROLOGICAL REHABILITATION BY CANADIAN PHYSIOTHERAPISTS
18. PROGNOSTIC VALUE OF A CARDIAC DAMAGE STAGING CLASSIFICATION IN PATIENTS WITH ASYMPTOMATIC PRIMARY MITRAL REGURGITATION
19. ASSOCIATION OF AORTIC BIOPROSTHETIC CALCIFICATION MEASURED BY CT WITH HEMODYNAMIC AND CLINICAL OUTCOMES
20. On the road to biomarkers: developing a robust system for miRNA evaluation in equine blood and synovial fluid
21. DETERMINANTS AND IMPACT OF LEFT VENTRICULAR ASYMMETRIC REMODELING ON LEFT VENTRICULAR FUNCTION IN PATIENTS WITH AORTIC STENOSIS - RESULTS FROM THE PROGRESSA STUDY
22. WARFARIN THERAPY ACCELERATES THE PROGRESSION RATE OF CALCIFIC AORTIC VALVE STENOSIS
23. HUMAN EPIDIDYMIS PROTEIN 4 (HE4) IS ASSOCIATED WITH OUTCOME IN LOW-FLOW, LOW-GRADIENT AORTIC STENOSIS
24. INTEREST OF PRE-OPERATIVE LONGITUDINAL STRAIN AND STRAIN RATE FOR THE PREDICTION OF REDUCED EJECTION FRACTION AFTER SURGERY FOR PURE AORTIC REGURGITATION
25. FORWARD EJECTION FRACTION TO IMPROVE RISK STRATIFICATION IN PATIENTS WITH PRIMARY MITRAL REGURGITATION
26. SEX-RELATED HISTOLOGICAL DISCREPANCIES IN AORTIC STENOSIS: CONTRIBUTION OF VALVULAR FIBROSIS TO THE PATHOPHYSIOLOGY OF THE DISEASE
27. HIGHER APOLIPOPROTEIN B / APOLIPOPROTEIN A-I RATIO IS ASSOCIATED WITH FASTER HEMODYNAMIC PROGRESSION OF AORTIC STENOSIS IN YOUNGER PATIENTS - RESULTS FROM THE PROGRESSA STUDY-
28. PROGNOSTIC VALUE OF INCREASE IN SYSTOLIC PULMONARY ARTERIAL PRESSURE AT LOW LEVEL OF EXERCISE IN ASYMPTOMATIC PATIENTS WITH ORGANIC MITRAL REGURGITATION -RESULTS FROM THE PROGRAM STUDY
29. IMPACT OF VASCULAR BURDEN IN AORTIC STENOSIS SEVERITY ASSESSMENT OF NORMAL FLOW-LOW GRADIENT PATIENTS
30. Chaos of protein folding.
31. Parameter-based prediction of speech quality in listening context—Towards a WB E-model.
32. REGRESSION OF CALCIFIC AORTIC VALVE STENOSIS: A NOVEL FUNCTION FOR VALVE INTERSTITIAL CELLS AND CARBONIC ANHYDRASE XII
33. P2Y2 Receptor-Mediated Expression of Carbonic Anhydrase XII and Functional Interaction With SLC4A3/AE3 Promotes Regression of Valve Mineralisation in Calcific Aortic Valve Disease
34. Perception of loudness changes induced by a phononic crystal in specific frequency bands
35. 718 Regression of Mineralization by Carbonic Anhydrase XII: Possible Therapeutical Implications for the Treatment of Calcified Aortic Valve Stenosis
36. 584 Circulating Matrix GLA Protein and Faster Progression Rate of Aortic Stenosis - a Substudy of the Astronomer Trial
37. 007 Inflammation is Associated With Aortic Valve Remodelling During Calcification
38. 006 Angiotensin Receptor Blockers Induce a Reduction of Fibrosis and Expression of MMP12 in Calcific Aortic Valve Disease
39. Evaluation of in vitro properties of di-tri-octahedral smectite on clostridial toxins and growth.
40. 483 Extracellular ATP prevents aortic valve mineralization by P2Y2 activation and PI3K/AKT survival pathway
41. 461 Angiotensine-receptors blockers but not angiotensin-converting enzime inhibitors delay the progression of aortic stenosis
42. 405 Impact of insulin resistance on progression of left ventricular hypertrophy in patients with aortic stenosis: A substudy of the astronomer trial
43. 240 VITAMIN K ROLE IN ARTERIAL STIFFNESS DURING METABOLIC SYNDROME IN RAT: DIRECT OR INDIRECT EFFECT VIA LIPID METABOLISM
44. The inversion of tradition.
45. IN PATIENTS WITH TYPE 2 DIABETES LOWER PLASMA LEVEL OF MATRIX GLA PROTEIN IS ASSOCIATED WITH FASTER AORTIC STENOSIS PROGRESSION
46. EXPRESSION OF CARBOXYLATED MATRIX GLA PROTEIN IN HUMAN AORTIC STENOSIS
47. COLOCALIZATION OF FIBRILLAR AMYLOID AND APOLIPOPROTEINS IN CALCIFIC AORTIC STENOSIS: POTENTIAL ROLE IN PATHOPHYSIOLOGY OF THE DISEASE?
48. Distinction of Becker from limb-girdle muscular dystrophy by means of dystrophin cDNA probes.
49. Advancements in web-database applications for rabies surveillance
50. Demonstrating scientific principles.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.